USPTO serial 99615963
INLIGHT
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- MMEJE, OBIEZE GINIKANWA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INLIGHT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sara Bauer
Sara Bauer Womble Bond Dickinson (US) LLP470 Atlantic Avenue, Suite 600Independence WharfBoston, MA 02210Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | genetic medicines for the treatment of diseases and disorders with known genetic cause, component and diseases states resulting from gene expression and genetic sequence; Pharmaceutical preparations for the treatment of obesity, metabolic, and cardiometabolic diseases and disorders; Pharmaceutical preparations for the treatment of genetic diseases and disorders | ACTIVE | — |
| 042 | Research and development in the field of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 13, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 13, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 13, 2026 | ALIE | ASSIGNED TO LIE | — |
| Sep 3, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 30, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 30, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 30, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 17, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 26, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 26, 2026 | NWAP | NEW APPLICATION ENTERED | — |